Continued from page 1
* Metabolife supplement and brain damages. A jury in Houston awarded $7.4 million to a woman who suffered brain damage in a stroke, as a consequence of taking
Metabolife supplement to lose weight. She had been persuaded by commercials that this supplement was safe and had no side effects.
* Mendacious campaigns for
Ephedra-based supplement Trimspa. An American hypnotist, Alex Szynalski, and a former Playboy Bunny (Anna Nicole Smith) joined in a Trimspa commercial which was considered "deceptive advertising" by
New Jersey Attorney General. The hypnotist was accused of luring consumers to his Goen Lose Weight Hypnosis seminars and then tempting them to buy
Trimspa supplements he produced.
* Kava Kava stop sales. Health Canada launched a public warning that this herb, found in supplements and sometimes in food is under suspicion. Its consumption was linked to liver disfunction and toxicity. FDA warned that
Kava extract is delivered under many other names which are difficult to find on
label (kava, kava kava, kava-kava, kava root, kava-kava root, kavain, kava pepper, kavapipar, kawa, kawa kawa, kawa pepper, kawapfeffer, maori kava, rhizoma di kava-kava, ava, ava pepper, ava root, awa, gea, gi, intoxicating pepper, intoxicating long pepper, kao, Piper methysticum, Macropiper Latifolium, Piper inebrians, Malohu, maluk, meruk, milik, kew, Rauschpfeffer, sakau, tonga, Wurzelstock, yagona, yangona, yaqona, yongona).
* The invisible Zoller laboratories. Intrigued by
name of diet pills suggested to be taken by Britney Spears, somebody tried to identify
producer of Zantrex 3. Zoller laboratories, apparently producing Zantrex 3, were not listed in any database. They were just a firm created by Basic Research,
company distributing Zantrex 3, for fear that its real name would sound too scientific to
public. The confusion induced by this phantom company nevertheless affected
credibility of
company.

Dana Scripca writes for http://www.dietpillscentral.com where you can find more information about Diet Pills. Please feel free to use this article in your Newsletter or on your website. If you use this article, please include the resource box and send a brief message to let me know where it appeared. mailto: danascri@gmail.com